Eleven years after its inception, and in such a rapidly evolving environment, Oxford PharmaGenesis™ has never been more committed to behaving ethically and responsibly at the interface between the pharmaceutical industry and healthcare. As such, representatives from our UK and US offices were invited to provide regular input and support to the development process of the guidelines. In addition, as a precursor to publication of the new guidelines, these colleagues, together with a well-known publisher, were commissioned by Pharmaceutical Marketing Europe to develop a feature article on the imminent arrival of the second iteration of Good Publication Practice. A copy of this article, "New Clarity" can be found here.

A series of lectures, entitled 'Addicted to Big Pharma? Reconciling business, medical and ethical needs', was recently organized by Oxford's newest college, Green Templeton. Influential speakers from pharmaceutical R&D, NICE, Oxfam and the ABPI addressed topic such as the origins of the industry, its relationships with government and society and whether it has a healthy future. The college has brought together Green College's medical knowledge and Templeton College's commercial acumen
to forge a powerhouse of pharmaceutical expertise.
http://www.gtc.ox.ac.uk/academic/lectures-seminars/green-templeton-lectures-2009.html

At Oxford PharmaGenesis™ we recognize that digital communications and social media will be important and growing parts of future pharmaceutical marketing. Chris Thomas, Marketing Partner, appears as a guest blogger in the last week of every month on 'Thinking Pharma', a website that takes
a thoughtful and sometimes provocative look at the digital future for pharma.
http://www.thinkingpharma.com/2009/07/it-was-easy-when-i-started.html